| Pathological findings of COVID-19 associated with acute respiratory distress syndrome Z Xu, L Shi, Y Wang, J Zhang, L Huang, C Zhang, S Liu, P Zhao, H Liu, ... The Lancet respiratory medicine 8 (4), 420-422, 2020 | 10388 | 2020 |
| SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19 Y Wang, S Liu, H Liu, W Li, F Lin, L Jiang, X Li, P Xu, L Zhang, L Zhao, ... Journal of hepatology 73 (4), 807-816, 2020 | 678 | 2020 |
| Clinical and pathological investigation of patients with severe COVID-19 S Li, L Jiang, X Li, F Lin, Y Wang, B Li, T Jiang, W An, S Liu, H Liu, P Xu, ... JCI insight 5 (12), 2020 | 282 | 2020 |
| Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus Y Wang, X Zhou, Y Debing, K Chen, LJW Van Der Laan, J Neyts, ... Gastroenterology 146 (7), 1775-1783, 2014 | 198 | 2014 |
| Modeling rotavirus infection and antiviral therapy using primary intestinal organoids Y Yin, M Bijvelds, W Dang, L Xu, AA van der Eijk, K Knipping, N Tuysuz, ... Antiviral research 123, 120-131, 2015 | 181 | 2015 |
| Ribavirin Inhibits In Vitro Hepatitis E Virus Replication through Depletion of Cellular GTP Pools and Is Moderately Synergistic with Alpha Interferon Y Debing, SU Emerson, Y Wang, Q Pan, J Balzarini, K Dallmeier, J Neyts Antimicrobial agents and chemotherapy 58 (1), 267-273, 2014 | 158 | 2014 |
| Hepatitis E virus infects neurons and brains X Zhou, F Huang, L Xu, Z Lin, FMS de Vrij, AC Ayo-Martin, ... The Journal of infectious diseases 215 (8), 1197-1206, 2017 | 119 | 2017 |
| Rapamycin and everolimus facilitate hepatitis E virus replication: revealing a basal defense mechanism of PI3K-PKB-mTOR pathway X Zhou, Y Wang, HJ Metselaar, HLA Janssen, MP Peppelenbosch, Q Pan Journal of hepatology 61 (4), 746-754, 2014 | 116 | 2014 |
| Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections W Wang, Y Yin, L Xu, J Su, F Huang, Y Wang, PPC Boor, K Chen, ... Science signaling 10 (476), eaah4248, 2017 | 82 | 2017 |
| Cross talk between nucleotide synthesis pathways with cellular immunity in constraining hepatitis E virus replication Y Wang, W Wang, L Xu, X Zhou, E Shokrollahi, K Felczak, ... Antimicrobial agents and chemotherapy 60 (5), 2834-2848, 2016 | 82 | 2016 |
| RIG‐I is a key antiviral interferon‐stimulated gene against hepatitis E virus regardless of interferon production L Xu, W Wang, Y Li, X Zhou, Y Yin, Y Wang, RA de Man, ... Hepatology 65 (6), 1823-1839, 2017 | 80 | 2017 |
| Mitochondrial fusion via OPA1 and MFN1 supports liver tumor cell metabolism and growth M Li, L Wang, Y Wang, S Zhang, G Zhou, R Lieshout, B Ma, J Liu, C Qu, ... Cells 9 (1), 121, 2020 | 75 | 2020 |
| Convergent Transcription of Interferon-stimulated Genes by TNF-α and IFN-α Augments Antiviral Activity against HCV and HEV W Wang, L Xu, JH Brandsma, Y Wang, MS Hakim, X Zhou, Y Yin, ... Scientific reports 6 (1), 25482, 2016 | 72 | 2016 |
| Mycophenolic acid potently inhibits rotavirus infection with a high barrier to resistance development Y Yin, Y Wang, W Dang, L Xu, J Su, X Zhou, W Wang, K Felczak, ... Antiviral research 133, 41-49, 2016 | 61 | 2016 |
| IFN regulatory factor 1 restricts hepatitis E virus replication by activating STAT1 to induce antiviral IFN‐stimulated genes L Xu, X Zhou, W Wang, Y Wang, Y Yin, LJW van der Laan, D Sprengers, ... The FASEB Journal 30 (10), 3352-3367, 2016 | 60 | 2016 |
| Recapitulating hepatitis E virus–host interactions and facilitating antiviral drug discovery in human liver–derived organoids P Li, Y Li, Y Wang, J Liu, M Lavrijsen, Y Li, R Zhang, MMA Verstegen, ... Science advances 8 (3), eabj5908, 2022 | 53 | 2022 |
| The RNA genome of hepatitis E virus robustly triggers an antiviral interferon response W Wang, Y Wang, C Qu, S Wang, J Zhou, W Cao, L Xu, B Ma, MS Hakim, ... Hepatology 67 (6), 2096-2112, 2018 | 49 | 2018 |
| Chronic hepatitis E in a renal transplant recipient: the first report of genotype 4 hepatitis E virus caused chronic infection in organ recipient Y Wang, G Chen, Q Pan, J Zhao Gastroenterology 154 (4), 1199-1201, 2018 | 47 | 2018 |
| Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality Y Wang, H Rao, X Chi, B Li, H Liu, L Wu, H Zhang, S Liu, G Zhou, N Li, ... EBioMedicine 46, 227-235, 2019 | 45 | 2019 |
| RDW, NLR and RLR in predicting liver failure and prognosis in patients with hepatitis E virus infection J Wu, X Zhang, H Liu, N Guo, Q Pan, Y Wang Clinical Biochemistry 63, 24-31, 2019 | 42 | 2019 |
